Full name
INSTITUTE OF CLINICAL RESEARCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
INSTITUTE OF CLINICAL RESEARCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. CICHOCIEMNYCH 4 / 9, 03-984 WARSZAWA
TAX ID1132818548
Rate company:
INSTITUTE OF CLINICAL RESEARCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID1132818548
KRS0000369847
Share capital50,000.00 zł
address
UL. CICHOCIEMNYCH 4 / 9, 03-984 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1132818548
REGON
142658927
KRS
0000369847
Legal form
limited liability company
Register Address
UL. CICHOCIEMNYCH 4 / 9, 03-984 WARSZAWA
Date of registration in KRS
2010-11-08
Date of commencement of economic activity
2010-11-08
Act signature
WA.XIV NS-REJ.KRS/39209/24/485
Pkd codes
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
46.51.Z - Wholesale of computers, peripheral equipment and software
47.91.Z - Retail sale via mail order houses or via Internet
55.20.Z - Holiday and other short-stay accommodation
62.09.Z - Other information technology and computer service activities
68.32.Z - Management of real estate on a fee or contract basis
72.11.Z - Research and experimental development on biotechnology
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | -0,1 | -0 | -0,2 | -1070,3 |
EBITDA | -0,1 | 0 | -0,2 | -1056,3 |
Short time liabilities | 0,6 | 0,5 | 0,4 | -17,9 |
Equity capital | 0,3 | 0,2 | 0,1 | -69,8 |
Operating profit (EBIT) | -0,1 | 0 | -0,2 | -1631,2 |
Assets | 0,9 | 0,8 | 0,5 | -38,6 |
Net profit (loss) | -0,1 | -0 | -0,2 | -924,3 |
Cash | 0,1 | 0 | 0 | -81,4 |
Net income from sale | 0,8 | 1,2 | 0,6 | -47,1 |
Liabilities and provisions for liabilities | 0,6 | 0,6 | 0,4 | -25,2 |
Working assets | 0,8 | 0,8 | 0,5 | -38,1 |
Depreciation | 0 | 0 | 0 | -0 |
% | % | % | p.p. | |
Profitability of capital | -46,1 | -6,8 | -231 | -224,2 |
Equity capital to total assets | 29,3 | 29,9 | 14,7 | -15,2 |
Gross profit margin | -15,1 | -1,2 | -26,5 | -25,3 |
EBITDA Margin | -12,5 | 1,4 | -25,2 | -26,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 287 | 157 | 243 | 86 |
Current financial liquidity indicator | 1.3445531129837036 | 1.555068850517273 | 1.1722649335861206 | -0,4 |
Net dept to EBITDA | -1.9640990495681763 | 9.298428535461426 | -0.43546217679977417 | -9,7 |
Financial statements
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
RECTO sp. z o.o.
Mikołów
FUNDACJA ARTYSTYCZNA OPERA VIVA
DĄBROWA
Softronic sp. z o.o.
Poznań
BSC Av sp. z o.o.
Warszawa